Caliway Biopharmaceuticals Co Ltd(TW:6919)
NT$71.60-0.40 (-0.56%)
TW:6919
Caliway Biopharmaceuticals Co Ltd earnings date
NT$71.60
At close:-0.40 (-0.56%)
Want to see TW:6919 full AI Analyst Report?
Caliway Biopharmaceuticals Co Ltd (6919) Q2 2024 Earnings Report
TW:6919 Q2 2024 EPS Results
- Actual EPS
- -TWD 0.12
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -TWD 0.21
TW:6919 Q2 2024 Revenue Results
- Actual Revenue
- TWD 7.85M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- -48.47%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/13/2024
- Time
- Before Open
- Conference Call
- Tuesday, August 13, 2024
TW:6919 Upcoming Earnings
Caliway Biopharmaceuticals Co Ltd's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
TW:6919 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | ―- | 0.05 | ― | ― |
| Nov 11, 2026 | 2026 (Q3) | ―-0.23 | -0.01 | -4560.00% (-0.23) | |
| Aug 03, 2026 | 2026 (Q2) | ―-0.14 | -0.16 | 10.00% (+0.02) | |
| Apr 10, 2026 | 2026 (Q1) | -0.22-0.07 | -0.11 | 38.60% (+0.04) | |
| Feb 24, 2026 | 2025 (Q4) | -0.170.05 | -0.14 | 138.24% (+0.19) | |
| Nov 07, 2025 | 2025 (Q3) | -0.19-0.01 | -0.09 | 94.44% (+0.09) | |
| Aug 08, 2025 | 2025 (Q2) | -0.13-0.16 | -0.12 | -39.13% (-0.04) | |
| May 05, 2025 | 2025 (Q1) | -0.15-0.11 | -0.16 | 27.39% (+0.04) | |
| Feb 07, 2025 | 2024 (Q4) | -0.13-0.14 | -0.18 | 25.27% (+0.05) | |
| Nov 10, 2024 | 2024 (Q3) | -0.13-0.09 | -0.21 | 57.55% (+0.12) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

